HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 102.72
(-1.37%)
CNY 102.72
(-1.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -107.6 Million CNY | -21.76% |
| 2022 | -88.37 Million CNY | 78.91% |
| 2021 | -418.97 Million CNY | -2728.39% |
| 2020 | -14.81 Million CNY | 63.59% |
| 2019 | -40.68 Million CNY | 14.33% |
| 2018 | -47.49 Million CNY | -306.84% |
| 2017 | 22.96 Million CNY | -6.42% |
| 2016 | 24.53 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 2.44 Million CNY | -89.3% |
| 2024 Q1 | -33.92 Million CNY | 68.48% |
| 2024 Q2 | 12.92 Million CNY | 138.1% |
| 2023 Q3 | -126.14 Million CNY | -61.89% |
| 2023 FY | -107.6 Million CNY | -21.76% |
| 2023 Q1 | -59.43 Million CNY | 32.75% |
| 2023 Q4 | -107.6 Million CNY | 14.69% |
| 2023 Q2 | -77.91 Million CNY | -31.1% |
| 2022 Q4 | -88.37 Million CNY | -68.72% |
| 2022 Q3 | -52.38 Million CNY | -90.1% |
| 2022 Q2 | -27.55 Million CNY | 72.24% |
| 2022 Q1 | -99.26 Million CNY | 76.31% |
| 2022 FY | -88.37 Million CNY | 78.91% |
| 2021 Q1 | -474.95 Million CNY | -3106.28% |
| 2021 Q2 | -77.58 Million CNY | 83.66% |
| 2021 FY | -418.97 Million CNY | -2728.39% |
| 2021 Q4 | -418.97 Million CNY | -255.29% |
| 2021 Q3 | -117.92 Million CNY | -51.99% |
| 2020 FY | -14.81 Million CNY | 63.59% |
| 2020 Q4 | -14.81 Million CNY | -73.84% |
| 2020 Q3 | -8.52 Million CNY | -29.41% |
| 2020 Q2 | -6.58 Million CNY | -107.26% |
| 2020 Q1 | 90.76 Million CNY | 323.06% |
| 2019 Q4 | -40.68 Million CNY | 0.0% |
| 2019 FY | -40.68 Million CNY | 14.33% |
| 2018 FY | -47.49 Million CNY | -306.84% |
| 2017 FY | 22.96 Million CNY | -6.42% |
| 2016 FY | 24.53 Million CNY | 0.0% |